Farallon Capital Management »

Maze Therapeatics shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 373k 29.85

More positions owned by Farallon Capital Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option
Revolution Medicines (RVMD)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Aon Shs Cl A (AON)
Bridgebio Pharma (BBIO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option
Protagonist Therapeutics (PTGX)
Natera (NTRA)
Exelixis (EXEL)
Broadcom (AVGO)
UnitedHealth (UNH)
Synopsys (SNPS)
Boston Scientific Corporation (BSX)
Thermo Fisher Scientific (TMO)

View all positions for Farallon Capital Management

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Arch Venture Corp
Deep Track Capital
Henderson Group
Paradigm Biocapital Advisors
BlackRock
AH Capital Management
VR Adviser
Vanguard Capital Management
Alphabet
Logos Global Management
Adage Capital Partners GP
General Catalyst Group Management
TRV GP V

View all funds holding Maze Therapeatics